Humana Inc.
HUMHealthcareNASDAQHealthcare Plans · Last scanned May 29, 2026
Scan Results
Daily timeframe2 of 4 indicators bearish as of May 28CONFIRMED
Multi-indicator alignment: When 2+ indicators show the same condition on the same day, Scanance highlights it. This is not a recommendation — it means the technical indicators are aligned.
Part of the healthcare sector, Humana Inc. (HUM) is listed under Healthcare Plans. Valued at $37.06B, HUM is a large-cap name in its sector. It operates in two segments, Insurance and CenterWell.
Market Cap
$37.06B
Beta
0.68
P/E (TTM)
32.91
P/E (Fwd)
19.82
EPS (TTM)
$9.38
EPS (Fwd)
$15.58
ROE
6.3%
ROA
3.6%
Cash
$21.97B
Total Debt
$14.37B
Free CF
$1.43B
52W Change
32.4%
Annual Financials
Cash vs Debt
The balance sheet looks solid with $21.97B in cash comfortably exceeding the $14.37B debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Annual free cash flow of $1.43B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 6.3% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.6% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $83.06B (2021) to $129.66B (2025), reflecting a 56% increase over the period.
The relatively low beta of 0.68 suggests HUM is a less volatile holding compared to the broader index. No single metric tells the full story. Reviewing HUM's risk profile alongside its fundamentals and technical indicators provides a more complete picture.